Treatment of Chronic Hepatitis C Genotype 3 With Ledipasvir and Sofosbuvir: An Observational Study

OBJECTIVE: Sofosbuvir/ledipasvir (SOF/LED) is recommended for treatment of genotypes 1, 4, 5 and 6. Despite some preliminary data from the ELECTRON-2 trial regarding use of SOF/LED combination in chronic hepatitis C genotype 3, there are no guidelines recommending this combination in such patients....

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Clin Exp Hepatol
Asıl Yazarlar: Dar, Gulzar A., Yattoo, Ghulam N., Gulzar, Ghulam M., Sodhi, Jaswinder S., Gorka, Suresh, Laway, Mushtaq A.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Elsevier 2021
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7953013/
https://ncbi.nlm.nih.gov/pubmed/33746448
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jceh.2020.06.011
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller